SAN FRANCISCO – In a head-to-head comparison of two biodegradable-polymer drug-eluting stents, BioMatrix demonstrated noninferiority to Orsiro in Korean patients undergoing percutaneous coronary intervention, according to study results presented Sunday at Transcatheter Cardiovascular Therapeutics 2019.